Public Profile

Hetero Labs

Hetero Labs, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Asia, Europe, and the Americas. Founded in 1993, the company has established itself as a leader in the development and manufacturing of high-quality generic medications, active pharmaceutical ingredients (APIs), and biosimilars. Hetero Labs is renowned for its commitment to innovation and quality, offering a diverse portfolio of products that cater to therapeutic areas such as oncology, HIV, and hepatitis. The company’s unique approach to research and development has led to significant milestones, including the launch of several first-to-market generics. With a strong market position, Hetero Labs continues to achieve notable recognition for its contributions to affordable healthcare solutions globally.

DitchCarbon Score

How does Hetero Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Hetero Labs's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Hetero Labs's reported carbon emissions

Hetero Labs, headquartered in India, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their current impact on climate change or their strategic approach to reducing carbon emissions. The absence of emissions data suggests a potential area for improvement in transparency and accountability regarding their environmental footprint. As the pharmaceutical industry increasingly prioritises sustainability, Hetero Labs may benefit from establishing clear climate commitments and measurable reduction targets to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hetero Labs's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Hetero Labs is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hetero Labs is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

CDP
UN

Akzonobel

NL
Chemicals
Updated 11 days ago

Caswell Adhesives

GB
Chemicals
Updated 11 days ago

FMC BioPolymer A.S.

NO
Chemicals
Updated 3 days ago

MANAPHARMA

EG
Chemicals
Updated 10 days ago

Copps Industries

US
Chemicals
Updated 11 days ago

JAYSHREE AROMATICS

IN
Chemicals
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers